Publications by authors named "Seonyoung Yang"

Claim this Profile
L
Longevity of immune-response provided by at least one dose of vi-DT vaccine 5 years after vaccination among healthy Filipino adults and children.
Rejwana Haque Pial, Maria Rosario Capeding, Birkneh Tilahun Tadesse, Jean-Louis Excler, Katerina Rok Song, Jae Seung Yang, Seon-Young Yang

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study.
Rejwana Haque Pial, Maria Rosario Capeding, Katerina Rok Song, Eun Lyeong Park, Il-Yeon Park, Jae Seung Yang, Seon-Young Yang

Vaccine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Arabidopsis thaliana ecotype Ct-1 achieves higher salt tolerance relative to Col-0 via higher tissue retention of K and NO.
Jun Ho Choi, Seokjin Lee, Quang Tri Le, Seonyoung Yang, Hojoung Lee

J Plant Physiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arabidopsis ecotype Ct-1, with its altered nitrate sensing ability, exhibits enhanced growth under low nitrate conditions in comparison to Col-0.
Seokjin Lee, Quang Tri Le, Seonyoung Yang, Kwang Yeon Hwang, Hojoung Lee

Plant Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced growth performance of abi5 plants under high salt and nitrate is associated with reduced nitric oxide levels.
Quang Tri Le, Hai An Truong, Dinh Thanh Nguyen, Seonyoung Yang, Liming Xiong

J Plant Physiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age.
Josefina Cadorna Carlos, Birkneh Tilahun Tadesse, Charissa Borja-Tabora, Edison Alberto, Michelle C Ylade, Jae Seung Yang, Seon-Young Yang

Lancet Reg Health West Pac· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 3-month cytogenetic and molecular assays for early assessment of long-term clinical impact after BCR-ABL1 tyrosine kinase inhibitor treatment in chronic myeloid leukemia.
Kyung-Mi Kee, Soo-Hyun Kim, Seon-Young Yang, Jeong-U Shin, Yoon-Won Nam

Leuk Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
Maria Rosario Capeding, Birkneh Tilahun Tadesse, Arijit Sil, Edison Alberto, Deok Ryun Kim, Jae Seung Yang, Seon-Young Yang

NPJ Vaccines· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study.
Maria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, Tarun Saluja, Samuel Teshome, Jae Seung Yang, Seon-Young Yang

EClinicalMedicine· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.
Maria Rosario Capeding, Edison Alberto, Arijit Sil, Tarun Saluja, Samuel Teshome, Jae Seung Yang, Seon-Young Yang

Vaccine· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia.
Hyejin Shin, Soo Young Choi, Kyung-Mi Kee, Soo-Hyun Kim, Seon-Young Yang

Int J Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.
Ki-Hoon Kang, Soo-Hyun Kim, Soo-Young Choi, Hae-Lyun Yoo, Mi-Young Lee, Seon-Young Yang

Leuk Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors.
Hye-Young Song, Hayeon Noh, Soo Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Seon-Young Yang

Cancer Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
Maria Rosario Capeding, Samuel Teshome, Tarun Saluja, Khalid Ali Syed, Deok Ryun Kim, Jae Seung Yang, Yang Hee Kim, Seon-Young Yang

Vaccine· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide functional analysis of pathogenicity genes in the rice blast fungus.
Junhyun Jeon, Sook-Young Park, Myoung-Hwan Chi, Jaehyuk Choi, Jongsun Park, Seonyoung Yang

Nat Genet· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis